Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

967474

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to secure funding for existing prescribed medicines withdrawal centres.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9967
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9968 HL9969 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967475

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have, if any, to increase the number of prescribed medicines withdrawal centres to cover the whole of England.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9968
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9969 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967476

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they will ensure that in establishing a 24 hour helpline for people affected by prescribed medicines addiction they will also ensure that adequate services are in place to refer patients to.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9969
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9968 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967478

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Benzodiazepines: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they will establish a public inquiry into the harmful effects of prescribed benzodiazepine drug dependence over the last 50 years.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9971
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9968 HL9969 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967470

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Visitors
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what training health visitors receive to enable them to identify incipient and actual cases of ante-natal depression, post-natal depression, and other maternal mental health issues.
	tabling member printed	Baroness Hodgson of Abinger
	uin	HL9964
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>Health visitors are part of the nursing profession and regulated by the Nursing and Midwifery Council (NMC). Health visitors are qualified and registered nurses or midwives who have undertaken an approved training programme in Specialist Community Public Health Nursing - Health Visiting.</p><p>The NMC has the general function of promoting high standards of education and coordinating all stages of education to ensure that health visitors are equipped with the knowledge, skills and attitudes essential for professional practice, including continuous professional development (CPD). The NMC set the standards of education and training for the nursing profession expected at undergraduate and postgraduate level and approve curricula set by individual higher education institutes. In so doing, they set out the knowledge, skills and behaviours that both postgraduate and undergraduate nurses must be able to demonstrate.</p><p>CPD is a term used to describe a number of different training and development activities which may be required for the purposes of professional practice in the National Health Service. The NMC requires 35 hours of CPD relevant to scope of practice in the three year period since registration was last renewed, or joining the register.</p><p>The NMC are in the process of rewriting their standards. For example, in the new pre-registration nursing standards the NMC specify that registrants must have proficiencies in identifying risk and vulnerability, in all settings and across the lifespan and would expect post-natal depression to be included in the curriculum.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9965 question first answered 17/09/2018 13:50:13 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4301 label Biography information for Baroness Hodgson of Abinger

967472

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Visitors
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what continuous professional development health visitors are required to undertake to enable them to identify incipient and actual cases of ante-natal depression, post-natal depression, and other maternal mental health issues.
	tabling member printed	Baroness Hodgson of Abinger
	uin	HL9965
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>Health visitors are part of the nursing profession and regulated by the Nursing and Midwifery Council (NMC). Health visitors are qualified and registered nurses or midwives who have undertaken an approved training programme in Specialist Community Public Health Nursing - Health Visiting.</p><p>The NMC has the general function of promoting high standards of education and coordinating all stages of education to ensure that health visitors are equipped with the knowledge, skills and attitudes essential for professional practice, including continuous professional development (CPD). The NMC set the standards of education and training for the nursing profession expected at undergraduate and postgraduate level and approve curricula set by individual higher education institutes. In so doing, they set out the knowledge, skills and behaviours that both postgraduate and undergraduate nurses must be able to demonstrate.</p><p>CPD is a term used to describe a number of different training and development activities which may be required for the purposes of professional practice in the National Health Service. The NMC requires 35 hours of CPD relevant to scope of practice in the three year period since registration was last renewed, or joining the register.</p><p>The NMC are in the process of rewriting their standards. For example, in the new pre-registration nursing standards the NMC specify that registrants must have proficiencies in identifying risk and vulnerability, in all settings and across the lifespan and would expect post-natal depression to be included in the curriculum.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9964 question first answered 17/09/2018 13:50:13 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4301 label Biography information for Baroness Hodgson of Abinger

967440

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Community Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether the number of district nurses in England in community service organisations, such as NHS Community Healthcare Trusts, has reduced since 2010; and, if so, what measures they are taking to address any problems caused by such a reduction.
	tabling member printed	Baroness Cox
	uin	HL9937
	answer	answer is ministerial correction date of answer 18/09/2018 answer text <p>Community health care services are a crucial part of the health and social care system that allows patients to be cared for at the right time in the right place.</p><p>NHS Digital data shows a reduction in the number of full time equivalent district nurses in England from 7,546 in September 2010 to 4,587 in May 2018. These include staff working in hospital trusts and clinical commissioning groups, but not staff working in primary care or in general practitioner surgeries, local authorities or other providers. The number of district nurses in independent healthcare providers increased by 273, from September 2010 to September 2017. As a result of changes made in 2009 to the ways in which community services are provided – i.e. from a range of different types of provider – this does not represent the full picture and there will be a number of district nurses providing National Health Service services in organisations that do not provide a return to the Electronic Staff Records.</p><p>The training of new district nurses is important in maintaining a workforce that can deliver the needs of the population in the community. Health Education England has commissioned and funded the District Nursing Specialist Practice Qualification at a steady state over the last six years. These are based upon the requirements that local providers have informed Health Education England. However, year on year these commissions are not fully taken up and therefore Health Education England is working to better understand the reasons this may be.</p><p>Health Education England is now exploring the capacity and capability required of our community workforce to best meet the future needs of the population. Health Education England is evaluating the skills and knowledge required within the wider community workforce including district nurses. This has involved extensive engagement across England to understand how best to meet to needs of the local population, as well as develop a role that has a more desirable career pathway for prospective healthcare professionals. The Government is also supporting incentives for postgraduates who go on to work in community nursing roles, including ‘golden hellos’.</p><p>Patient safety remains a key priority for the Department and in 2017 we restated our commitment to the NHS being the “safest healthcare system in the world”. The Care Quality Commission (CQC) assesses all registered providers that deliver regulated activities against the Fundamental Standards, below which the standard of care must not fall. Staffing is one of the Standards, and the CQC inspections check that sufficient numbers of suitably qualified, competent, skilled and experienced staff are deployed within service providers. To this effect we would expect providers to continue to ensure patient safety in the community.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9938 question first answered 18/09/2018 11:36:58 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3364 label Biography information for Baroness Cox

967441

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Community Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what measures they are taking to ensure patient safety and wellbeing in the light of the expected reduction in funding for district nurse training in England from September 2019.
	tabling member printed	Baroness Cox
	uin	HL9938
	answer	answer is ministerial correction date of answer 18/09/2018 answer text <p>Community health care services are a crucial part of the health and social care system that allows patients to be cared for at the right time in the right place.</p><p>NHS Digital data shows a reduction in the number of full time equivalent district nurses in England from 7,546 in September 2010 to 4,587 in May 2018. These include staff working in hospital trusts and clinical commissioning groups, but not staff working in primary care or in general practitioner surgeries, local authorities or other providers. The number of district nurses in independent healthcare providers increased by 273, from September 2010 to September 2017. As a result of changes made in 2009 to the ways in which community services are provided – i.e. from a range of different types of provider – this does not represent the full picture and there will be a number of district nurses providing National Health Service services in organisations that do not provide a return to the Electronic Staff Records.</p><p>The training of new district nurses is important in maintaining a workforce that can deliver the needs of the population in the community. Health Education England has commissioned and funded the District Nursing Specialist Practice Qualification at a steady state over the last six years. These are based upon the requirements that local providers have informed Health Education England. However, year on year these commissions are not fully taken up and therefore Health Education England is working to better understand the reasons this may be.</p><p>Health Education England is now exploring the capacity and capability required of our community workforce to best meet the future needs of the population. Health Education England is evaluating the skills and knowledge required within the wider community workforce including district nurses. This has involved extensive engagement across England to understand how best to meet to needs of the local population, as well as develop a role that has a more desirable career pathway for prospective healthcare professionals. The Government is also supporting incentives for postgraduates who go on to work in community nursing roles, including ‘golden hellos’.</p><p>Patient safety remains a key priority for the Department and in 2017 we restated our commitment to the NHS being the “safest healthcare system in the world”. The Care Quality Commission (CQC) assesses all registered providers that deliver regulated activities against the Fundamental Standards, below which the standard of care must not fall. Staffing is one of the Standards, and the CQC inspections check that sufficient numbers of suitably qualified, competent, skilled and experienced staff are deployed within service providers. To this effect we would expect providers to continue to ensure patient safety in the community.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9937 question first answered 18/09/2018 11:36:58 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3364 label Biography information for Baroness Cox

967409

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Public Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how much funding is being made available to Public Health England to support the implementation of proposals contained in their report A consensus statement: reproductive health is a public issue, published on 26 June.
	tabling member printed	Baroness Barker
	uin	HL9910
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>Implementation of the proposals in Public Health England’s <em>A consensus statement: reproductive health is a public issue</em> will be funded from existing budgets.</p><p>Funding allocations for sexual and reproductive health are not set centrally by the Department and will be determined within the organisations concerned.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9911 question first answered 17/09/2018 13:54:05 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2501 label Biography information for Baroness Barker

967410

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Public Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how much additional funding, if any, is being made available to local authorities to support the implementation of proposals in Public Health England’s A consensus statement: reproductive health is a public issue, published on 26 June.
	tabling member printed	Baroness Barker
	uin	HL9911
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>Implementation of the proposals in Public Health England’s <em>A consensus statement: reproductive health is a public issue</em> will be funded from existing budgets.</p><p>Funding allocations for sexual and reproductive health are not set centrally by the Department and will be determined within the organisations concerned.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9910 question first answered 17/09/2018 13:54:05 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2501 label Biography information for Baroness Barker

967406

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Public Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what has been the process for developing Public Health England’s upcoming reproductive health action plan referenced on page 5 of Public Health England’s A consensus statement: reproductive health is a public issue; and when will that action plan be published.
	tabling member printed	Baroness Barker
	uin	HL9907
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>Public Health England (PHE) has created a task and finish group made up of representatives from organisations across the sector including the Department, NHS England, the Local Government Association, the Association of Directors of Public Health, the Faculty of Sexual and Reproductive Health, the Royal College of General Practitioners, the Royal College of Nursing, the Royal College of Midwives, the Royal College of Gynaecology, Brook, and the Family Planning Association. The task and finish group will work together to inform the development and implementation of the reproductive health action plan. Alongside this, PHE is also working with a user reference group, made up of women who have experienced severe reproductive health issues in order to ensure the action plan reflects service users’ needs. The action plan is due to be published in March 2019.</p><p>In addition, PHE’s regional centres are developing an approach for localising the national research conducted and developing locally appropriate actions in addition to those being driven nationally. PHE are consulting with commissioners and providers in developing the action plan through workshops and presentations across the country and to ensure implementation of the action plan from 2019 onwards.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9908 HL9909 question first answered 17/09/2018 14:03:21 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2501 label Biography information for Baroness Barker

967407

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Public Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether Public Health England will consult external stakeholders during the development of the reproductive health action plan referenced on page 5 of Public Health England’s A consensus statement: reproductive health is a public issue.
	tabling member printed	Baroness Barker
	uin	HL9908
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>Public Health England (PHE) has created a task and finish group made up of representatives from organisations across the sector including the Department, NHS England, the Local Government Association, the Association of Directors of Public Health, the Faculty of Sexual and Reproductive Health, the Royal College of General Practitioners, the Royal College of Nursing, the Royal College of Midwives, the Royal College of Gynaecology, Brook, and the Family Planning Association. The task and finish group will work together to inform the development and implementation of the reproductive health action plan. Alongside this, PHE is also working with a user reference group, made up of women who have experienced severe reproductive health issues in order to ensure the action plan reflects service users’ needs. The action plan is due to be published in March 2019.</p><p>In addition, PHE’s regional centres are developing an approach for localising the national research conducted and developing locally appropriate actions in addition to those being driven nationally. PHE are consulting with commissioners and providers in developing the action plan through workshops and presentations across the country and to ensure implementation of the action plan from 2019 onwards.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9907 HL9909 question first answered 17/09/2018 14:03:21 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2501 label Biography information for Baroness Barker

967408

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Public Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to implement the proposals in Public Health England’s A consensus statement: reproductive health is a public issue, published on 26 June.
	tabling member printed	Baroness Barker
	uin	HL9909
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>Public Health England (PHE) has created a task and finish group made up of representatives from organisations across the sector including the Department, NHS England, the Local Government Association, the Association of Directors of Public Health, the Faculty of Sexual and Reproductive Health, the Royal College of General Practitioners, the Royal College of Nursing, the Royal College of Midwives, the Royal College of Gynaecology, Brook, and the Family Planning Association. The task and finish group will work together to inform the development and implementation of the reproductive health action plan. Alongside this, PHE is also working with a user reference group, made up of women who have experienced severe reproductive health issues in order to ensure the action plan reflects service users’ needs. The action plan is due to be published in March 2019.</p><p>In addition, PHE’s regional centres are developing an approach for localising the national research conducted and developing locally appropriate actions in addition to those being driven nationally. PHE are consulting with commissioners and providers in developing the action plan through workshops and presentations across the country and to ensure implementation of the action plan from 2019 onwards.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9907 HL9908 question first answered 17/09/2018 14:03:21 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2501 label Biography information for Baroness Barker

947564

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	PrescQIPP
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the accuracy of the information provided by PrescQIPP to Clinical Commissioning Groups to aid their commissioning decisions.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9847
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>We have not made any assessment on the accuracy and advice provided by PrescQIPP. Nor have we made any assessment on whether the advice provided by PrescQIPP to clinical commissioning groups (CCGs) is consistent with national guidelines on the prescription of liothyronine to National Health Service patients. We can confirm that we have not received any assurances from PrescQIPP on whether or not it has taken patient stakeholder views into account as it is the responsibility of CCGs to seek any such assurances.</p><p>PrescQIPP is an independent social enterprise and it is for CCGs to decide whether and how they take that guidance into account when making decisions. However, NHS England expects CCGs to have due regard to the guidance <em>Items which should not routinely be prescribed in primary care: Guidance for CCGs,</em> published in November 2017 by NHS England and NHS Clinical Commissioners when considering the prescribing of liothyronine. A copy of the guidance is attached.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9848 HL9849 question first answered 26/07/2018 12:46:36 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name items-which-should-not-be-routinely-precscribed-in-pc-ccg-guidance.pdf title Items which should not routinely be prescribed
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947566

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of whether the advice provided by PresQIPP to Clinical Commissioning Groups is consistent with national guidelines on the prescription of Liothryonine (T3) to NHS patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9848
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>We have not made any assessment on the accuracy and advice provided by PrescQIPP. Nor have we made any assessment on whether the advice provided by PrescQIPP to clinical commissioning groups (CCGs) is consistent with national guidelines on the prescription of liothyronine to National Health Service patients. We can confirm that we have not received any assurances from PrescQIPP on whether or not it has taken patient stakeholder views into account as it is the responsibility of CCGs to seek any such assurances.</p><p>PrescQIPP is an independent social enterprise and it is for CCGs to decide whether and how they take that guidance into account when making decisions. However, NHS England expects CCGs to have due regard to the guidance <em>Items which should not routinely be prescribed in primary care: Guidance for CCGs,</em> published in November 2017 by NHS England and NHS Clinical Commissioners when considering the prescribing of liothyronine. A copy of the guidance is attached.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9847 HL9849 question first answered 26/07/2018 12:46:36 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name items-which-should-not-be-routinely-precscribed-in-pc-ccg-guidance.pdf title Items which should not routinely be prescribed
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947567

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	PrescQIPP
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assurances they have received from PresQIPP that when providing guidance to Clinical Commissioning Groups on commissioning decisions it has taken the views of patient stakeholders into account.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9849
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>We have not made any assessment on the accuracy and advice provided by PrescQIPP. Nor have we made any assessment on whether the advice provided by PrescQIPP to clinical commissioning groups (CCGs) is consistent with national guidelines on the prescription of liothyronine to National Health Service patients. We can confirm that we have not received any assurances from PrescQIPP on whether or not it has taken patient stakeholder views into account as it is the responsibility of CCGs to seek any such assurances.</p><p>PrescQIPP is an independent social enterprise and it is for CCGs to decide whether and how they take that guidance into account when making decisions. However, NHS England expects CCGs to have due regard to the guidance <em>Items which should not routinely be prescribed in primary care: Guidance for CCGs,</em> published in November 2017 by NHS England and NHS Clinical Commissioners when considering the prescribing of liothyronine. A copy of the guidance is attached.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9847 HL9848 question first answered 26/07/2018 12:46:36 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name items-which-should-not-be-routinely-precscribed-in-pc-ccg-guidance.pdf title Items which should not routinely be prescribed
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947553

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Community Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the financial challenges faced by nurses in England where they take a reduction in salary for the duration of the one-year education programme to qualify as a district nurse.
	tabling member printed	Baroness Cox
	uin	HL9839
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>Community health services play a crucial role in keeping people living healthier for longer through proactively managing health in a setting where patients feel most comfortable. Having the right workforce is fundamental to ensure this can happen and the Government acknowledges the challenge of meeting increased demand for care from community nurses.</p><p>We want to do more to support nurses, including those facing financial difficulty, who undertake the one-year education programme to qualify as a district nurse. On 9 May 2018, the Minister of State for Health (Stephen Barclay) announced that some postgraduate students starting district nursing courses will be eligible to receive up to £10,000 as a 'golden hello’. The Government announced £10 million to support this and we are currently considering how this is best delivered on the ground. Health Education England has agreed to provide funding for all community nursing specialist practice qualifications until 2020. In addition to this, we are expanding routes into district nursing by developing an apprenticeship.</p><p>Employers across the National Health Service are responsible for rostering their staff effectively, including providing cover for staff who are on training, to ensure they can deliver excellent patient care. Health Education England is currently considering how to further support the community nursing workforce.</p><p>Health Education England has advised they are grateful to Dr Bob Brown, Queen’s Nursing Institute, for raising his concerns regarding the future development of the district nurse workforce. A full written response to Dr Brown’s letter is being sent imminently.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9840 HL9841 question first answered 26/07/2018 12:43:40 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3364 label Biography information for Baroness Cox

947554

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Community Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what measures they are taking to reduce any impact on patient care resulting from the absence of funding to backfill a post when a registered nurse in the district nursing team undertakes a year-long programme of education in order to qualify as a district nurse.
	tabling member printed	Baroness Cox
	uin	HL9840
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>Community health services play a crucial role in keeping people living healthier for longer through proactively managing health in a setting where patients feel most comfortable. Having the right workforce is fundamental to ensure this can happen and the Government acknowledges the challenge of meeting increased demand for care from community nurses.</p><p>We want to do more to support nurses, including those facing financial difficulty, who undertake the one-year education programme to qualify as a district nurse. On 9 May 2018, the Minister of State for Health (Stephen Barclay) announced that some postgraduate students starting district nursing courses will be eligible to receive up to £10,000 as a 'golden hello’. The Government announced £10 million to support this and we are currently considering how this is best delivered on the ground. Health Education England has agreed to provide funding for all community nursing specialist practice qualifications until 2020. In addition to this, we are expanding routes into district nursing by developing an apprenticeship.</p><p>Employers across the National Health Service are responsible for rostering their staff effectively, including providing cover for staff who are on training, to ensure they can deliver excellent patient care. Health Education England is currently considering how to further support the community nursing workforce.</p><p>Health Education England has advised they are grateful to Dr Bob Brown, Queen’s Nursing Institute, for raising his concerns regarding the future development of the district nurse workforce. A full written response to Dr Brown’s letter is being sent imminently.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9839 HL9841 question first answered 26/07/2018 12:43:40 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3364 label Biography information for Baroness Cox

947555

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Community Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is their response to the letter sent on 22 June by Dr Bob Brown, Trustee of the Queen’s Nursing Institute and chair the Community Nurse Executive Network, to Health Education England, which highlighted the lack of funding from Health Education England to support district nurse education after September.
	tabling member printed	Baroness Cox
	uin	HL9841
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>Community health services play a crucial role in keeping people living healthier for longer through proactively managing health in a setting where patients feel most comfortable. Having the right workforce is fundamental to ensure this can happen and the Government acknowledges the challenge of meeting increased demand for care from community nurses.</p><p>We want to do more to support nurses, including those facing financial difficulty, who undertake the one-year education programme to qualify as a district nurse. On 9 May 2018, the Minister of State for Health (Stephen Barclay) announced that some postgraduate students starting district nursing courses will be eligible to receive up to £10,000 as a 'golden hello’. The Government announced £10 million to support this and we are currently considering how this is best delivered on the ground. Health Education England has agreed to provide funding for all community nursing specialist practice qualifications until 2020. In addition to this, we are expanding routes into district nursing by developing an apprenticeship.</p><p>Employers across the National Health Service are responsible for rostering their staff effectively, including providing cover for staff who are on training, to ensure they can deliver excellent patient care. Health Education England is currently considering how to further support the community nursing workforce.</p><p>Health Education England has advised they are grateful to Dr Bob Brown, Queen’s Nursing Institute, for raising his concerns regarding the future development of the district nurse workforce. A full written response to Dr Brown’s letter is being sent imminently.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9839 HL9840 question first answered 26/07/2018 12:43:40 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3364 label Biography information for Baroness Cox

947547

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Community Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what measures they are taking to address the impact of the reduction in the number of district nurses in England from 7,700 in 2010 to 4,400 in 2018, as reported by NHS Digital.
	tabling member printed	Baroness Cox
	uin	HL9837
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>Community health services play a crucial role in keeping people living healthier for longer through proactively managing health in a setting where patients feel most comfortable. Having the right workforce is fundamental to ensure this can happen and the Government acknowledges the challenge of meeting increased demand for care from community nurses.</p><p> </p><p>NHS Digital’s data, which is drawn from the Electronic Staff Record, shows a drop in the number of full-time equivalent district nurses across the National Health Service. However, because of changes, made in 2009, to the way that community health services are commissioned – i.e. to a range of different types of provider – this does not represent the full picture and there will be many district nurses providing NHS funded services in organisations that do not provide a return to the Electronic Staff Record.</p><p> </p><p>However, we are not complacent, which is why we are increasing the supply of registered nurses to meet the growth in demand and have announced additional clinical placement funding that will enable around 5,000 more nursing students to enter training each year from September 2018. This is a historic increase.</p><p> </p><p>We are committed to developing and supporting the wellbeing of the whole community workforce to deliver safe, quality patient-centred care. Health Education England is currently considering how to further support the community nursing workforce.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9838 question first answered 26/07/2018 12:52:37 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3364 label Biography information for Baroness Cox

947551

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Community Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the impact on patient safety and wellbeing of the falling numbers of district nurses in England reported by NHS Digital.
	tabling member printed	Baroness Cox
	uin	HL9838
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>Community health services play a crucial role in keeping people living healthier for longer through proactively managing health in a setting where patients feel most comfortable. Having the right workforce is fundamental to ensure this can happen and the Government acknowledges the challenge of meeting increased demand for care from community nurses.</p><p> </p><p>NHS Digital’s data, which is drawn from the Electronic Staff Record, shows a drop in the number of full-time equivalent district nurses across the National Health Service. However, because of changes, made in 2009, to the way that community health services are commissioned – i.e. to a range of different types of provider – this does not represent the full picture and there will be many district nurses providing NHS funded services in organisations that do not provide a return to the Electronic Staff Record.</p><p> </p><p>However, we are not complacent, which is why we are increasing the supply of registered nurses to meet the growth in demand and have announced additional clinical placement funding that will enable around 5,000 more nursing students to enter training each year from September 2018. This is a historic increase.</p><p> </p><p>We are committed to developing and supporting the wellbeing of the whole community workforce to deliver safe, quality patient-centred care. Health Education England is currently considering how to further support the community nursing workforce.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9837 question first answered 26/07/2018 12:52:36 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3364 label Biography information for Baroness Cox

942019

	registered interest
	date	16/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they have carried out any research into the number of potential beneficiaries of a relaxation of the current restrictions on the use of medicinal cannabis.
	tabling member printed	Lord Bassam of Brighton
	uin	HL9533
	answer	answer is ministerial correction date of answer 25/07/2018 answer text <p>The Government has not commissioned research into the number of patients that might benefit from use of cannabis-based medicinal products.</p><p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU. The Government will continue to monitor and share the emerging evidence on the therapeutic use of cannabis-based medicinal products.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9534 question first answered 25/07/2018 11:46:44 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3504 label Biography information for Lord Bassam of Brighton

942020

	registered interest
	date	16/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to ensure that research into the use of medicinal cannabis as a potential treatment will be shared following the UK exiting the EU.
	tabling member printed	Lord Bassam of Brighton
	uin	HL9534
	answer	answer is ministerial correction date of answer 25/07/2018 answer text <p>The Government has not commissioned research into the number of patients that might benefit from use of cannabis-based medicinal products.</p><p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU. The Government will continue to monitor and share the emerging evidence on the therapeutic use of cannabis-based medicinal products.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9533 question first answered 25/07/2018 11:46:44 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3504 label Biography information for Lord Bassam of Brighton

940070

	registered interest
	date	12/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Records: Databases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to ensure that individual independent healthcare providers are engaged in the design and delivery of the Acute Data Alignment Programme.
	tabling member printed	Baroness Jolly
	uin	HL9485
	answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>Engagement with key stakeholders including independent healthcare providers and organisations who represent such providers will be crucial to the success of the Acute Data Alignment Programme. A communications plan is currently being developed which will identify the timing and method of communication. The Programme will engage relevant stakeholder groups as the work develops.</p><p>The initial objectives of the Programme will be to understand the issues and potential barriers to aligning the information collected for both National Health Service funded and private patients. This will inform the proposed approach which will be published for open consultation prior to the implementation phase.</p><p>The Programme is designed to improve alignment between data collection and management across sectors to increase transparency for patients, commissioners, clinicians and the providers themselves. This will include general practitioners.</p><p>Phase one of the Programme will see co-operation between all parties to accelerate publication of information mandated by the Competition and Markets Authority following its Private Healthcare Market Investigation Order 2014. Phase two will aim to redirect the flow of data for approximately 750,000 privately funded hospital episodes each year to NHS Digital. A public consultation on the scope and objectives will be launched later this year.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9486 HL9487 question first answered 23/07/2018 13:49:37 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4203 label Biography information for Baroness Jolly

940071

	registered interest
	date	12/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Records: Databases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, following the launch of the Acute Data Alignment Programme, what measures they plan to introduce to ensure that independent healthcare providers can collect and submit data in the same way as NHS providers.
	tabling member printed	Baroness Jolly
	uin	HL9486
	answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>Engagement with key stakeholders including independent healthcare providers and organisations who represent such providers will be crucial to the success of the Acute Data Alignment Programme. A communications plan is currently being developed which will identify the timing and method of communication. The Programme will engage relevant stakeholder groups as the work develops.</p><p>The initial objectives of the Programme will be to understand the issues and potential barriers to aligning the information collected for both National Health Service funded and private patients. This will inform the proposed approach which will be published for open consultation prior to the implementation phase.</p><p>The Programme is designed to improve alignment between data collection and management across sectors to increase transparency for patients, commissioners, clinicians and the providers themselves. This will include general practitioners.</p><p>Phase one of the Programme will see co-operation between all parties to accelerate publication of information mandated by the Competition and Markets Authority following its Private Healthcare Market Investigation Order 2014. Phase two will aim to redirect the flow of data for approximately 750,000 privately funded hospital episodes each year to NHS Digital. A public consultation on the scope and objectives will be launched later this year.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9485 HL9487 question first answered 23/07/2018 13:49:37 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4203 label Biography information for Baroness Jolly

940072

	registered interest
	date	12/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Records: Databases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, following the launch of the Acute Data Alignment Programme, what measures they plan to introduce to ensure that GPs are able to view full patient journeys within both the NHS and the independent healthcare sector.
	tabling member printed	Baroness Jolly
	uin	HL9487
	answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>Engagement with key stakeholders including independent healthcare providers and organisations who represent such providers will be crucial to the success of the Acute Data Alignment Programme. A communications plan is currently being developed which will identify the timing and method of communication. The Programme will engage relevant stakeholder groups as the work develops.</p><p>The initial objectives of the Programme will be to understand the issues and potential barriers to aligning the information collected for both National Health Service funded and private patients. This will inform the proposed approach which will be published for open consultation prior to the implementation phase.</p><p>The Programme is designed to improve alignment between data collection and management across sectors to increase transparency for patients, commissioners, clinicians and the providers themselves. This will include general practitioners.</p><p>Phase one of the Programme will see co-operation between all parties to accelerate publication of information mandated by the Competition and Markets Authority following its Private Healthcare Market Investigation Order 2014. Phase two will aim to redirect the flow of data for approximately 750,000 privately funded hospital episodes each year to NHS Digital. A public consultation on the scope and objectives will be launched later this year.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9485 HL9486 question first answered 23/07/2018 13:49:37 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4203 label Biography information for Baroness Jolly

935170

	registered interest
	date	05/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Minimum Wage
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of any potential threat to the viability of social care providers caused by the Employment Appeal Tribunal ruling on backdating sleep-in pay.
	tabling member printed	Baroness Hollins
	uin	HL9287
	answer	answer is ministerial correction date of answer 11/07/2018 answer text <p>The Government recognises the pressure that sleep-in back pay liabilities are placing on providers of social care, and is exploring options to minimise any impact on the sector. Any intervention to support the sector would need to be proportionate and necessary.</p><p>The Government commissioned market analysis to assess the impact of sleep-ins back pay liabilities across the social care sector. This work forms part of the evidence base that is being used to assess options and is subject to further analysis and refinement. The Department has committed to sharing a summary of the analysis at the appropriate time.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9288 question first answered 11/07/2018 15:31:00 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4190 label Biography information for Baroness Hollins

935171

	registered interest
	date	05/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Minimum Wage
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment, if any, they have made of the estimate, produced by Mencap, that the Employment Appeal Tribunal decision to backdate pay for sleep-in carers will lead to a funding shortfall of £400 million for care organisations.
	tabling member printed	Baroness Hollins
	uin	HL9288
	answer	answer is ministerial correction date of answer 11/07/2018 answer text <p>The Government recognises the pressure that sleep-in back pay liabilities are placing on providers of social care, and is exploring options to minimise any impact on the sector. Any intervention to support the sector would need to be proportionate and necessary.</p><p>The Government commissioned market analysis to assess the impact of sleep-ins back pay liabilities across the social care sector. This work forms part of the evidence base that is being used to assess options and is subject to further analysis and refinement. The Department has committed to sharing a summary of the analysis at the appropriate time.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9287 question first answered 11/07/2018 15:31:00 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4190 label Biography information for Baroness Hollins

935153

	registered interest
	date	05/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Prisons
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they intend to provide improved mental health care for prisoners following the estimates produced by the Centre for Mental Health, published in June, which suggest that there are 21,000 mentally ill people in prison but only 3,600 beds available for mental health patients.
	tabling member printed	Lord Carlile of Berriew
	uin	HL9270
	answer	answer is ministerial correction date of answer 19/07/2018 answer text <p>We recognise that there are high numbers of people in prison with mental ill health, and it is essential that they are treated in the most appropriate environment for their needs.</p><p> </p><p>Whilst some prisoners may be mentally unwell, and despite sometimes complex emotional and behavioural needs, it may not be clinically appropriate for them to be transferred to a mental health inpatient bed. There may be other services more appropriate to their needs that can be delivered outside inpatient mental health facilities.</p><p> </p><p>There are no plans for a review. However there is already work underway to ensure people are diverted to mental health care services outside prison either before or on their release, and to improve mental health services within prisons.</p><p> </p><p>Liaison and Diversion services operate at police stations and courts, to identify and assess people with vulnerabilities (substance misuse, mental health problems) and refer them into appropriate services and, where appropriate, away from the justice system altogether. Information from Liaison and Diversion assessments is used by the police and courts to inform sentencing decisions. These services cover 82% of the population with full roll out expected by 2020.</p><p> </p><p>The Department of Health and Social Care and the Ministry of Justice have worked with NHS England and Public Health England to develop a Community Sentence Treatment Requirement ‘protocol’. The protocol aims to increase the use of community sentences with drug, alcohol and mental health treatment requirements as an alternative to custody to improve health outcomes and reduce reoffending. It sets out what is expected from all involved agencies to ensure improved access to mental health and substance misuse treatment for offenders who need it.</p><p> </p><p>Work is also underway to improve support for prisoners whilst they are in prison. NHS England is focussing on an offender mental health pathway which will ensure that offenders are directed to the most appropriate intervention to their needs at the right time in the criminal justice system. The programme of work includes ensuring timely and appropriate transfers to a mental health hospital, timely remission to prison as part of a planned episode of care, and to ensure that those requiring treatment for mental ill health have access to high quality care.</p><p> </p><p>New service specifications have been published for both low and medium secure hospitals as well as prison mental health services. The Prison Mental Health Specification embeds the Quality Standards for Prison Mental Health Services developed by the Royal College of Psychiatrists to ensure high quality care for all. Draft guidance for timely and appropriate transfers and remissions of care to and from a mental health hospital is currently in production.</p><p> </p><p>Following release from prison, NHS England is working with partners to develop better pathways of care from custody. Drawing on learning from existing services we are investigating how best to ensure continuity of care post custody.</p><p> </p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL9271 question first answered 19/07/2018 14:43:02 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1138 label Biography information for Lord Carlile of Berriew

935154

	registered interest
	date	05/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Illness: Prisoners
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they plan to carry out a review into the number of prisoners with mental health issues in the UK in order to establish ways in which those suffering from serious mental health problems can be diverted to mental health care outside prison before or on release.
	tabling member printed	Lord Carlile of Berriew
	uin	HL9271
	answer	answer is ministerial correction date of answer 19/07/2018 answer text <p>We recognise that there are high numbers of people in prison with mental ill health, and it is essential that they are treated in the most appropriate environment for their needs.</p><p> </p><p>Whilst some prisoners may be mentally unwell, and despite sometimes complex emotional and behavioural needs, it may not be clinically appropriate for them to be transferred to a mental health inpatient bed. There may be other services more appropriate to their needs that can be delivered outside inpatient mental health facilities.</p><p> </p><p>There are no plans for a review. However there is already work underway to ensure people are diverted to mental health care services outside prison either before or on their release, and to improve mental health services within prisons.</p><p> </p><p>Liaison and Diversion services operate at police stations and courts, to identify and assess people with vulnerabilities (substance misuse, mental health problems) and refer them into appropriate services and, where appropriate, away from the justice system altogether. Information from Liaison and Diversion assessments is used by the police and courts to inform sentencing decisions. These services cover 82% of the population with full roll out expected by 2020.</p><p> </p><p>The Department of Health and Social Care and the Ministry of Justice have worked with NHS England and Public Health England to develop a Community Sentence Treatment Requirement ‘protocol’. The protocol aims to increase the use of community sentences with drug, alcohol and mental health treatment requirements as an alternative to custody to improve health outcomes and reduce reoffending. It sets out what is expected from all involved agencies to ensure improved access to mental health and substance misuse treatment for offenders who need it.</p><p> </p><p>Work is also underway to improve support for prisoners whilst they are in prison. NHS England is focussing on an offender mental health pathway which will ensure that offenders are directed to the most appropriate intervention to their needs at the right time in the criminal justice system. The programme of work includes ensuring timely and appropriate transfers to a mental health hospital, timely remission to prison as part of a planned episode of care, and to ensure that those requiring treatment for mental ill health have access to high quality care.</p><p> </p><p>New service specifications have been published for both low and medium secure hospitals as well as prison mental health services. The Prison Mental Health Specification embeds the Quality Standards for Prison Mental Health Services developed by the Royal College of Psychiatrists to ensure high quality care for all. Draft guidance for timely and appropriate transfers and remissions of care to and from a mental health hospital is currently in production.</p><p> </p><p>Following release from prison, NHS England is working with partners to develop better pathways of care from custody. Drawing on learning from existing services we are investigating how best to ensure continuity of care post custody.</p><p> </p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL9270 question first answered 19/07/2018 14:43:02 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1138 label Biography information for Lord Carlile of Berriew

934668

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of NHS warehousing requirements if frictionless trade with the EU is not maintained following Brexit.
	tabling member printed	Baroness Walmsley
	uin	HL9245
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>Patient safety is paramount in our exit negotiations and maintaining continuity of supply of medical products is a key part of ensuring patients continue to receive the safe high-quality care they need on day one of the exit from the European Union exit and thereafter.</p><p>The Department is working closely with cross Government agencies to ensure that there is no disruption to the supply of medical products following the United Kingdom’s withdrawal from the EU, regardless of the terms of the withdrawal.</p><p>This includes enhancing existing supply chain resilience, scoping out alternative sources of supply and providing means to access critical medical devices at short notice. Warehousing requirements for centrally held stock of medical devices for the National Health Service is continuously reviewed against demand patterns and forecasts which incorporate consideration of external factors, such as exiting the EU, and is integral to contingency planning. Medicines suppliers will be taking a similar approach to their stocks.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9246 question first answered 18/07/2018 16:13:57 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2547 label Biography information for Baroness Walmsley

934669

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of warehousing requirements for NHS suppliers if frictionless trade with the EU is not maintained following Brexit.
	tabling member printed	Baroness Walmsley
	uin	HL9246
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>Patient safety is paramount in our exit negotiations and maintaining continuity of supply of medical products is a key part of ensuring patients continue to receive the safe high-quality care they need on day one of the exit from the European Union exit and thereafter.</p><p>The Department is working closely with cross Government agencies to ensure that there is no disruption to the supply of medical products following the United Kingdom’s withdrawal from the EU, regardless of the terms of the withdrawal.</p><p>This includes enhancing existing supply chain resilience, scoping out alternative sources of supply and providing means to access critical medical devices at short notice. Warehousing requirements for centrally held stock of medical devices for the National Health Service is continuously reviewed against demand patterns and forecasts which incorporate consideration of external factors, such as exiting the EU, and is integral to contingency planning. Medicines suppliers will be taking a similar approach to their stocks.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9245 question first answered 18/07/2018 16:13:57 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2547 label Biography information for Baroness Walmsley

934655

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Organs: Donors
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many organ donations were made in England in each of the last five financial years by deceased individuals who were not on the Organ Donor Register.
	tabling member printed	Lord McColl of Dulwich
	uin	HL9232
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>NHS Blood and Transplant is responsible for organ donation and transplantation in the UK.</p><p>NHS Blood and Transplant have advised that the following table sets out information on the number of organ donors in England who were not registered on the NHS Organ Donor Register (ODR) and the number of donors who were registered.</p><p>The table also shows the number of families approached who did not consent to organ donation for eligible donors who had not expressed a wish to donate on the ODR or the donation wish was not known at time of approach. Also shown is the number of families approached who have overridden express consent for donation for potential donors who had expressed a wish to donate on the ODR and it was known at time of approach.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2013/2014</p></td><td><p>2014/2015</p></td><td><p>2015/2016</p></td><td><p>2016/2017</p></td><td><p>2017/2018</p></td></tr><tr><td><p>Number of deceased organ donors: - who were not registered on the ODR</p></td><td><p>653</p></td><td><p>597</p></td><td><p>640</p></td><td><p>660</p></td><td><p>692</p></td></tr><tr><td><p>- who were registered on the ODR</p></td><td><p>451</p></td><td><p>469</p></td><td><p>504</p></td><td><p>507</p></td><td><p>662</p></td></tr><tr><td><p>Number of families approached but who did not give consent to organ donation for an eligible donor who had not expressed a wish to donate on the ODR or donation wish was not known at time of approach</p></td><td><p>1,029</p></td><td><p>1,063</p></td><td><p>925</p></td><td><p>928</p></td><td><p>891</p></td></tr><tr><td><p>Number of families approached but who have overridden express consent to organ donation for an eligible donor who was on the ODR and this was known at time of approach</p></td><td><p>85</p></td><td><p>80</p></td><td><p>85</p></td><td><p>67</p></td><td><p>72</p></td></tr></tbody></table><p><em>Source:</em> NHS Blood and Transplant, 2018</p><p>Note:</p><p>All figures are for England.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9233 HL9234 HL9235 question first answered 18/07/2018 16:15:25 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1892 label Biography information for Lord McColl of Dulwich

934656

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Organs: Donors
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many organ donations were made in England in each of the last five financial years by deceased individuals who were on the Organ Donor Register.
	tabling member printed	Lord McColl of Dulwich
	uin	HL9233
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>NHS Blood and Transplant is responsible for organ donation and transplantation in the UK.</p><p>NHS Blood and Transplant have advised that the following table sets out information on the number of organ donors in England who were not registered on the NHS Organ Donor Register (ODR) and the number of donors who were registered.</p><p>The table also shows the number of families approached who did not consent to organ donation for eligible donors who had not expressed a wish to donate on the ODR or the donation wish was not known at time of approach. Also shown is the number of families approached who have overridden express consent for donation for potential donors who had expressed a wish to donate on the ODR and it was known at time of approach.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2013/2014</p></td><td><p>2014/2015</p></td><td><p>2015/2016</p></td><td><p>2016/2017</p></td><td><p>2017/2018</p></td></tr><tr><td><p>Number of deceased organ donors: - who were not registered on the ODR</p></td><td><p>653</p></td><td><p>597</p></td><td><p>640</p></td><td><p>660</p></td><td><p>692</p></td></tr><tr><td><p>- who were registered on the ODR</p></td><td><p>451</p></td><td><p>469</p></td><td><p>504</p></td><td><p>507</p></td><td><p>662</p></td></tr><tr><td><p>Number of families approached but who did not give consent to organ donation for an eligible donor who had not expressed a wish to donate on the ODR or donation wish was not known at time of approach</p></td><td><p>1,029</p></td><td><p>1,063</p></td><td><p>925</p></td><td><p>928</p></td><td><p>891</p></td></tr><tr><td><p>Number of families approached but who have overridden express consent to organ donation for an eligible donor who was on the ODR and this was known at time of approach</p></td><td><p>85</p></td><td><p>80</p></td><td><p>85</p></td><td><p>67</p></td><td><p>72</p></td></tr></tbody></table><p><em>Source:</em> NHS Blood and Transplant, 2018</p><p>Note:</p><p>All figures are for England.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9232 HL9234 HL9235 question first answered 18/07/2018 16:15:25 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1892 label Biography information for Lord McColl of Dulwich

934657

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Organs: Donors
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government in how many cases in each of the last five financial years families objected to organ donation on the part of a deceased donor who was not on the Organ Donation Register in England.
	tabling member printed	Lord McColl of Dulwich
	uin	HL9234
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>NHS Blood and Transplant is responsible for organ donation and transplantation in the UK.</p><p>NHS Blood and Transplant have advised that the following table sets out information on the number of organ donors in England who were not registered on the NHS Organ Donor Register (ODR) and the number of donors who were registered.</p><p>The table also shows the number of families approached who did not consent to organ donation for eligible donors who had not expressed a wish to donate on the ODR or the donation wish was not known at time of approach. Also shown is the number of families approached who have overridden express consent for donation for potential donors who had expressed a wish to donate on the ODR and it was known at time of approach.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2013/2014</p></td><td><p>2014/2015</p></td><td><p>2015/2016</p></td><td><p>2016/2017</p></td><td><p>2017/2018</p></td></tr><tr><td><p>Number of deceased organ donors: - who were not registered on the ODR</p></td><td><p>653</p></td><td><p>597</p></td><td><p>640</p></td><td><p>660</p></td><td><p>692</p></td></tr><tr><td><p>- who were registered on the ODR</p></td><td><p>451</p></td><td><p>469</p></td><td><p>504</p></td><td><p>507</p></td><td><p>662</p></td></tr><tr><td><p>Number of families approached but who did not give consent to organ donation for an eligible donor who had not expressed a wish to donate on the ODR or donation wish was not known at time of approach</p></td><td><p>1,029</p></td><td><p>1,063</p></td><td><p>925</p></td><td><p>928</p></td><td><p>891</p></td></tr><tr><td><p>Number of families approached but who have overridden express consent to organ donation for an eligible donor who was on the ODR and this was known at time of approach</p></td><td><p>85</p></td><td><p>80</p></td><td><p>85</p></td><td><p>67</p></td><td><p>72</p></td></tr></tbody></table><p><em>Source:</em> NHS Blood and Transplant, 2018</p><p>Note:</p><p>All figures are for England.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9232 HL9233 HL9235 question first answered 18/07/2018 16:15:25 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1892 label Biography information for Lord McColl of Dulwich

934658

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Organs: Donors
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government in how many cases in each of the last five financial years families objected to organ donation on the part of a deceased donor who was on the Organ Donor Register in England.
	tabling member printed	Lord McColl of Dulwich
	uin	HL9235
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>NHS Blood and Transplant is responsible for organ donation and transplantation in the UK.</p><p>NHS Blood and Transplant have advised that the following table sets out information on the number of organ donors in England who were not registered on the NHS Organ Donor Register (ODR) and the number of donors who were registered.</p><p>The table also shows the number of families approached who did not consent to organ donation for eligible donors who had not expressed a wish to donate on the ODR or the donation wish was not known at time of approach. Also shown is the number of families approached who have overridden express consent for donation for potential donors who had expressed a wish to donate on the ODR and it was known at time of approach.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2013/2014</p></td><td><p>2014/2015</p></td><td><p>2015/2016</p></td><td><p>2016/2017</p></td><td><p>2017/2018</p></td></tr><tr><td><p>Number of deceased organ donors: - who were not registered on the ODR</p></td><td><p>653</p></td><td><p>597</p></td><td><p>640</p></td><td><p>660</p></td><td><p>692</p></td></tr><tr><td><p>- who were registered on the ODR</p></td><td><p>451</p></td><td><p>469</p></td><td><p>504</p></td><td><p>507</p></td><td><p>662</p></td></tr><tr><td><p>Number of families approached but who did not give consent to organ donation for an eligible donor who had not expressed a wish to donate on the ODR or donation wish was not known at time of approach</p></td><td><p>1,029</p></td><td><p>1,063</p></td><td><p>925</p></td><td><p>928</p></td><td><p>891</p></td></tr><tr><td><p>Number of families approached but who have overridden express consent to organ donation for an eligible donor who was on the ODR and this was known at time of approach</p></td><td><p>85</p></td><td><p>80</p></td><td><p>85</p></td><td><p>67</p></td><td><p>72</p></td></tr></tbody></table><p><em>Source:</em> NHS Blood and Transplant, 2018</p><p>Note:</p><p>All figures are for England.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9232 HL9233 HL9234 question first answered 18/07/2018 16:15:25 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1892 label Biography information for Lord McColl of Dulwich

934633

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Contraceptives
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps, if any, they are taking to address the variation in cost for different forms of contraceptives available to women.
	tabling member printed	Baroness Barker
	uin	HL9210
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>No specific action is being taken to address variation in cost for different forms of contraception. Clinical commissioning groups expect prescribers to take the cost of medicines into account in their prescribing but the first consideration is always choosing the product which best meets the clinical need of the individual patient. Prescribed contraception is available free of charge to women on the National Health Service.</p><p>The Department has not conducted a specific assessment of price and health professionals’ contraceptive prescribing patterns.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9211 question first answered 18/07/2018 16:15:38 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2501 label Biography information for Baroness Barker

934634

	registered interest
	date	04/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Contraceptives
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of whether the variation in cost of contraceptives discourages health care professionals from offering the full range of contraceptives to women.
	tabling member printed	Baroness Barker
	uin	HL9211
	answer	answer is ministerial correction date of answer 18/07/2018 answer text <p>No specific action is being taken to address variation in cost for different forms of contraception. Clinical commissioning groups expect prescribers to take the cost of medicines into account in their prescribing but the first consideration is always choosing the product which best meets the clinical need of the individual patient. Prescribed contraception is available free of charge to women on the National Health Service.</p><p>The Department has not conducted a specific assessment of price and health professionals’ contraceptive prescribing patterns.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9210 question first answered 18/07/2018 16:15:38 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2501 label Biography information for Baroness Barker

932348

	registered interest
	date	28/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Foetal Alcohol Spectrum Disorder
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many patients with foetal alcohol spectrum disorders are receiving treatment on the NHS.
	tabling member printed	Baroness Gardner of Parkes
	uin	HL9060
	answer	answer is ministerial correction date of answer 11/07/2018 answer text <p>Information on numbers of patients with foetal alcohol spectrum disorders (FASD) receiving treatment on the National Health Service is not collected centrally.</p><p>The United Kingdom Chief Medical Officers’ low risk drinking guidelines advise women who are pregnant or think they could become pregnant that the safest approach is not to drink alcohol at all, to reduce risks to the baby to a minimum.</p><p>As part of the Maternity Transformation Programme, Public Health England (PHE) is leading work to provide prevention-focused leadership to support a reduction in the proportion of women drinking alcohol during pregnancy. Midwives and health visitors also have a role in providing clear, consistent advice and early identification and support. Additionally PHE’s Start4Life programme also provides online information on the impact of drinking alcohol during pregnancy, including the risk of FASD.</p><p>The Department for Education through the Adoption Support Fund has made funding available to local authorities to support adopted children with a range of specialist assessments and therapy to treat a variety of conditions. This includes FASD.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL9061 HL9062 question first answered 11/07/2018 11:10:35 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3596 label Biography information for Baroness Gardner of Parkes

932349

	registered interest
	date	28/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Foetal Alcohol Spectrum Disorder
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what information is provided to women to try to prevent foetal alcohol spectrum disorders.
	tabling member printed	Baroness Gardner of Parkes
	uin	HL9061
	answer	answer is ministerial correction date of answer 11/07/2018 answer text <p>Information on numbers of patients with foetal alcohol spectrum disorders (FASD) receiving treatment on the National Health Service is not collected centrally.</p><p>The United Kingdom Chief Medical Officers’ low risk drinking guidelines advise women who are pregnant or think they could become pregnant that the safest approach is not to drink alcohol at all, to reduce risks to the baby to a minimum.</p><p>As part of the Maternity Transformation Programme, Public Health England (PHE) is leading work to provide prevention-focused leadership to support a reduction in the proportion of women drinking alcohol during pregnancy. Midwives and health visitors also have a role in providing clear, consistent advice and early identification and support. Additionally PHE’s Start4Life programme also provides online information on the impact of drinking alcohol during pregnancy, including the risk of FASD.</p><p>The Department for Education through the Adoption Support Fund has made funding available to local authorities to support adopted children with a range of specialist assessments and therapy to treat a variety of conditions. This includes FASD.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL9060 HL9062 question first answered 11/07/2018 11:10:35 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3596 label Biography information for Baroness Gardner of Parkes

932350

	registered interest
	date	28/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Foetal Alcohol Spectrum Disorder
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what support is available to parents or adopters of children with foetal alcohol spectrum disorders.
	tabling member printed	Baroness Gardner of Parkes
	uin	HL9062
	answer	answer is ministerial correction date of answer 11/07/2018 answer text <p>Information on numbers of patients with foetal alcohol spectrum disorders (FASD) receiving treatment on the National Health Service is not collected centrally.</p><p>The United Kingdom Chief Medical Officers’ low risk drinking guidelines advise women who are pregnant or think they could become pregnant that the safest approach is not to drink alcohol at all, to reduce risks to the baby to a minimum.</p><p>As part of the Maternity Transformation Programme, Public Health England (PHE) is leading work to provide prevention-focused leadership to support a reduction in the proportion of women drinking alcohol during pregnancy. Midwives and health visitors also have a role in providing clear, consistent advice and early identification and support. Additionally PHE’s Start4Life programme also provides online information on the impact of drinking alcohol during pregnancy, including the risk of FASD.</p><p>The Department for Education through the Adoption Support Fund has made funding available to local authorities to support adopted children with a range of specialist assessments and therapy to treat a variety of conditions. This includes FASD.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL9060 HL9061 question first answered 11/07/2018 11:10:35 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3596 label Biography information for Baroness Gardner of Parkes

931656

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Aortic Aneurysm
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they have conducted an impact assessment of the draft NICE Guidelines on Abdominal Aortic Aneurysm, including the impact (1) on patients over 65 years old who may be medically unsuitable for open surgical repair, and (2) of removing certain treatment options when clinical professionals have indicated that patients require such treatment.
	tabling member printed	Baroness Walmsley
	uin	HL9003
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>We have made no such assessments. The National Institute for Health and Care Excellence (NICE) is an independent body and has not yet published final guidance on the diagnosis and management of abdominal aortic aneurysm. NICE has recently consulted on its draft guideline and will take the comments it has received in response to the consultation fully into account in finalising its recommendations.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9004 question first answered 09/07/2018 14:31:56 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2547 label Biography information for Baroness Walmsley

931658

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Aortic Aneurysm
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the availability to UK patients of fenestrated endografts, developed in the UK, manufactured in Scotland and used around the world, if the current draft NICE guidelines on Abdominal Aortic Aneurysm are implemented.
	tabling member printed	Baroness Walmsley
	uin	HL9004
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>We have made no such assessments. The National Institute for Health and Care Excellence (NICE) is an independent body and has not yet published final guidance on the diagnosis and management of abdominal aortic aneurysm. NICE has recently consulted on its draft guideline and will take the comments it has received in response to the consultation fully into account in finalising its recommendations.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9003 question first answered 09/07/2018 14:31:56 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2547 label Biography information for Baroness Walmsley

931632

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they propose to ensure that the Brighton and Sussex University Hospitals NHS Trust withdraws its policy of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8980
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8981 HL8982 HL8983 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931633

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they propose to take to ensure that the High Weald, Lewes and Havens Clinical Commissioning Group withdraws its policy of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8981
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8980 HL8982 HL8983 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931634

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the Brighton and Sussex University Hospitals NHS Trust mistakenly stating that the only option for patients wishing to continue Liothyronine (T3) therapy is through the private sector, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8982
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8980 HL8981 HL8983 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931635

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they propose to ensure that NHS bodies withdraw policies of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8983
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8980 HL8981 HL8982 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

930914

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the extent to which the commissioning guidance for the NHS and local government on how to respond to the needs of people who are addicted to prescription and over the counter medicines, published by Public Health England in June 2013, has been implemented.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8914
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>No assessment has been made of the extent to which the commissioning guidance has been implemented. Responding to the needs of people who are addicted to prescription and over the counter medicines is the responsibility of local authorities and the National Health Service in each area. Local authority and clinical commissioning group commissioners should work together to ensure that there are appropriate services and interventions available to meet the needs of their local populations.</p><p>Public Health England supports local commissioners to better understand and address local need, by publishing guidance and supplying information about people in touch with specialist substance misuse services who are being treated for addiction to medicines.</p><p>People who have developed problems with prescription and over the counter medicines should seek help from their general practitioner (GP) in the first instance. Specialist advice for GPs and support for patients with complex and severe problems is available from substance misuse services in each local authority across the country.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8915 question first answered 09/07/2018 14:18:52 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

930915

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the extent to which support is available in every area for people with a dependency on prescription or over the counter medicines as set out in the guidance published by Public Health England in June 2013.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8915
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>No assessment has been made of the extent to which the commissioning guidance has been implemented. Responding to the needs of people who are addicted to prescription and over the counter medicines is the responsibility of local authorities and the National Health Service in each area. Local authority and clinical commissioning group commissioners should work together to ensure that there are appropriate services and interventions available to meet the needs of their local populations.</p><p>Public Health England supports local commissioners to better understand and address local need, by publishing guidance and supplying information about people in touch with specialist substance misuse services who are being treated for addiction to medicines.</p><p>People who have developed problems with prescription and over the counter medicines should seek help from their general practitioner (GP) in the first instance. Specialist advice for GPs and support for patients with complex and severe problems is available from substance misuse services in each local authority across the country.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8914 question first answered 09/07/2018 14:18:52 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

930912

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they will ensure the timely publication of the agenda, papers and minutes of the Public Health England Expert Group on Prescribed Drug Dependence.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8912
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>Public Health England (PHE) has been commissioned to undertake a public health evidence review of available data and published evidence on the problems associated with dependence, and the short term discontinuation or longer term withdrawal symptoms, associated with prescribed medicines.</p><p> </p><p>PHE is aware of the importance and relevance of the experience of patients in understanding the issues. The review will include a call for papers which specifically identifies published accounts of the patients’ experiences, and this material will be specifically and deliberately focused on in the review. This process is distinct from a public inquiry, which would include individual testimony.</p><p> </p><p>PHE is committed to publishing the agenda, papers and minutes of meetings of the expert reference group and the first set of these documents will be available during July 2018.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8913 question first answered 09/07/2018 14:17:45 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath